Tournament: Loyola | Round: 1 | Opponent: Bellerina Hu | Judge: Truman Le
Feldman 1 Robin Feldman 2-11-2019 "'One-and-done' for new drugs could cut patent thickets and boost generic competition" https://www.statnews.com/2019/02/11/drug-patent-protection-one-done/ (Arthur J. Goldberg Distinguished Professor of Law, Albert Abramson '54 Distinguished Professor of Law Chair, and Director of the Center for Innovation)SidK + Elmer
Drug companies have
AND
for minimal benefit.
Feldman 2 Robin Feldman 18, May your drug price be evergreen, Journal of Law and the Biosciences, Volume 5, Issue 3, December 2018, Pages 590–647, https://doi.org/10.1093/jlb/lsy022 Arthur J. Goldberg Distinguished Professor of Law, Albert Abramson '54 Distinguished Professor of Law Chair, and Director of the Center for Innovation (Study Notes: Presenting the first comprehensive study of evergreening, this article examines the extent to which evergreening behavior—which can be defined as artificially extending the protection cliff—may contribute to the problem. The author analyses all drugs on the market between 2005 and 2015, combing through 60,000 data points to examine every instance in which a company added a new patent or exclusivity.)sid
The study results
AND
added to them.
Arnold Ventures 20 9-24-2020 "'Evergreening' Stunts Competition, Costs Consumers and Taxpayers" https://www.arnoldventures.org/stories/evergreening-stunts-competition-costs-consumers-and-taxpayers/ (Arnold Ventures is focused on evidence-based giving in a wide range of categories including: criminal justice, education, health care, and public finance)Elmer
Revlimid is a
AND
the delivery device.
Radhakrishnan 16 Priti Radhakrishnan 6-14-2016 "Pharma's secret weapon to keep drug prices high" https://www.statnews.com/2016/06/14/secondary-patent-gilead-sovaldi-harvoni/ (Priti Radhakrishnan is cofounder and director of the Initiative for Medicines, Access and Knowledge (I-MAK), a US-based nonprofit group of scientists and lawyers working globally to get people lifesaving medicines. Before founding I-MAK, she worked as a health attorney in the US, Switzerland, and India.)Elmer
Skyrocketing drug prices
AND
prevent legitimate competition.
Sobti 19 ~Dr. Navjot Kaur Sobti is an internal medicine resident physician at Dartmouth-Hitchcock-Medical Center/Dartmouth School of Medicine and a member of the ABC News Medical Unit. May 1, 2019. "Amid superbug crisis, scientists urge innovation". https://abcnews.go.com/Health/amidst-superbug-crisis-scientists-urge-innovation/story?id=62763415~~ Dhruv
The United Nations
AND
drug-resistant diseases."
Srivatsa '17 (Kadiyali; specialist in pediatric intensive and critical care medicine in the UK. Invented the bacterial identification tool 'MAYA'; 1-12-2017; "Superbug Pandemics and How to Prevent Them", American Interest; https://www.the-american-interest.com/2017/01/12/superbug-pandemics-and-how-to-prevent-them/, Accessed: 8-31-2021; AU)
It is by
AND
past fifty years.
NAS 8 National Academy of Sciences 12-3-2008 "The Role of the Life Sciences in Transforming America's Future Summary of a Workshop" Re-cut by Elmer
Fostering Industries to
AND
sustainably on earth.
Specktor 19 ~Brandon writes about the science of everyday life for Live Science, and previously for Reader's Digest magazine, where he served as an editor for five years~ 6-4-2019, "Human Civilization Will Crumble by 2050 If We Don't Stop Climate Change Now, New Paper Claims," livescience, https://www.livescience.com/65633-climate-change-dooms-humans-by-2050.html JW
The current climate
AND
as we know it."
3~ Expanding breadth of Pharma Innovation into neglected diseases results in global linkages that revitalizes global health diplomacy.
Hotez 16, Peter J. Blue marble health: an innovative plan to fight diseases of the poor amid wealth. JHU Press, 2016. (Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, Departments of Pediatrics and Molecular Virology and Microbiology)Elmer
We also need
AND
well as Nigeria ~11~.
Nang and Martin 17, Roberto N., and Keith Martin. "Global health diplomacy: A new strategic defense pillar." Military medicine 182.1-2 (2017): 1456-1460. (MC, Global Health Division, Uniformed Services University of the Health Sciences)Elmer
INTRODUCTION: FORCE IF
AND
and international interest.
Feldman 3 Robin Feldman 2-11-2019 "'One-and-done' for new drugs could cut patent thickets and boost generic competition" https://www.statnews.com/2019/02/11/drug-patent-protection-one-done/ (Arthur J. Goldberg Distinguished Professor of Law, Albert Abramson '54 Distinguished Professor of Law Chair, and Director of the Center for Innovation)SidK + Elmer
I believe that
AND
just too great.
Reforming the Patent Process would lower Drug Prices and incentivize Pharma Innovation by revitalizing the Market.
Stanbrook 13, Matthew B. "Limiting "evergreening" for a better balance of drug innovation incentives." (2013): 939-939. (MD (University of Toronto) PhD (University of Toronto))Elmer
At issue in
AND
maintain their profits.
Engelberg 19 ~Alfred B. Engelberg is a retired intellectual property lawyer and philanthropist. During his legal career, he was a patent examiner at the US Patent Office, a patent trial attorney at the US Department of Justice, and a member of the New York City law firm of Amster, Rothstein, and Engelberg. February 28, 2019. "A Shortfall In Innovation Is The Cause Of High Drug Prices". https://www.healthaffairs.org/do/10.1377/hblog20190228.636555/full/~~ Dhruv
A System That
AND
of new medicines.